Related Experiment Video
Updated: Jul 18, 2026

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
Opioid, cheating on its receptors, exacerbates pain
Christophe Altier1, Gerald W Zamponi
1Hotchkiss Brain Institute, Department of Physiology and Biophysics, University of Calgary, 3330 Hospital Drive NW, Calgary, Alberta T2N 4N1, Canada.
Elevated dynorphin levels unexpectedly activate bradykinin receptors, worsening neuropathic pain. This challenges the common view of opioids solely as pain relievers.
Area of Science:
- Neuroscience
- Pain Research
- Molecular Biology
Background:
- Opioids are widely recognized for their analgesic properties.
- Neuropathic pain is a chronic pain condition often resistant to conventional treatments.
Discussion:
- This study reveals a novel mechanism where elevated dynorphin, an endogenous opioid, activates bradykinin receptors.
- This interaction contributes significantly to the persistence of neuropathic pain.
Key Insights:
- Dynorphin's role extends beyond typical opioid pathways.
- Bradykinin receptor activation by dynorphin presents a new therapeutic target for neuropathic pain.
Outlook:
- Further research into the dynorphin-bradykinin pathway could lead to innovative pain management strategies.
- Understanding these complex interactions is crucial for developing more effective analgesics.
Related Concept Videos
Analgesia and Pain Management
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioid Receptors: Overview
Drug Abuse and Addiction: Pharmacological Phenomena
Pain

